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Molecular Rearrangements in the Ligand-Binding
Domain of Cyclic Nucleotide±Gated Channels
et al., 1987; Su et al., 1995), providing structural models
for the ligand-binding domain of CNG channels.
How the binding of cyclic nucleotide to this ligand-
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binding domain is coupled to channel opening is still²Department of Physiology and Biophysics
not understood at a molecular level. Channel activation³Howard Hughes Medical Institute
is thought to involve the initial binding of ligand, followedUniversity of Washington
by an opening allosteric transition (Karpen et al., 1988;Seattle, Washington 98105
Gordon and Zagotta, 1995). Both cGMP and cAMP bind
to the cyclic nucleotide±binding domain of the bovine
rod channel a subunit (CNG1). However, bound cGMPSummary
promotes the opening allosteric transition approxi-
mately three orders of magnitude better than boundCyclic nucleotide±gated (CNG) channels are activated
cAMP, making cAMP a very poor agonist for CNG1 chan-in response to the direct binding of cyclic nucleotides
nels (Gordon and Zagotta, 1995; Varnum et al., 1995;to an intracellular domain. This domain is thought to
Sunderman and Zagotta, 1999).contain a b roll and two a helices, designated the B
We have introduced single cysteine residues into theand C helices. To probe the conformational changes
ligand-binding domain of a ªcysteinelessº CNG1 chan-occurring in the ligand-binding domain during channel
nel and used cysteine-specific modifying reagents toactivation, we used the substituted cysteine accessi-
determine the accessibility of the residue in the closedbility method (SCAM). We found that a residue in the b
and unliganded, closed and liganded, and open states.roll, C505, is more accessible in unliganded channels
State-dependent changes in accessibility point to re-than in liganded channels, whereas a residue in the C
gions undergoing conformational changes during chan-helix, G597C, is more accessible in closed channels
nel activation. We found that two separate positions inthan in open channels. These results support a molec-
the ligand-binding domain of CNG1 are accessible inular mechanism for channel activation in which the
different states and show distinct effects in responseligand initially binds to the b roll, followed by an open-
to modification. We propose that these effects are theing allosteric transition involving the relative move-
result of different mechanisms of channel inhibition. Ourment of the C helix toward the b roll.
data, combined with known structural information from
the cyclic nucleotide±binding domain of CAP, support
a molecular mechanism for the conformational changesIntroduction
occurring in the ligand-binding domain of CNG1 during
channel activation. In this proposed mechanism, theCyclic nucleotide±gated (CNG) channels were first dis-
ligand initially binds to the b roll, followed by an openingcovered in the plasma membrane of the outer segment
allosteric conformational change involving the relativeof vertebrate rod photoreceptors, where they respond to
movement of the b roll and the C helix toward eachchanges in the intracellular concentration of guanosine
other.39:59-cyclic monophosphate (cGMP) to generate an
electrical response to light (Fesenko et al., 1985). Al-
Resultsthough CNG channels are only weakly voltage depen-
dent (Karpen et al., 1988), they share sequence similarity
We used the substituted cysteine accessibility method
with the voltage-dependent K1 channel family (Jan and
(SCAM) (Roberts et al., 1986; Falke et al., 1988; Akabas
Jan, 1990). Like voltage-dependent channels, CNG
et al., 1992, 1994) to study conformational changes oc-
channels are thought to form as tetramers, with each curring in the ligand-binding domain of the CNG1 chan-
subunit containing six transmembrane segments (S1± nel during channel activation. We initially characterized
S6), a P region, and intracellular N- and C-terminal do- the behavior of wild-type CNG1 channels, which contain
mains (Figure 1, top) (Kaupp et al., 1989; Molday et al., seven endogenous cysteines, by expressing CNG1
1991; Wohlfart et al., 1992; Henn et al., 1995; Liu et al., channels in Xenopus oocytes and using the patch-clamp
1996). Unlike voltage-dependent channels, CNG chan- technique to record from inside-out patches. We tested
nels contain an intracellular cyclic nucleotide±binding the effects of the cysteine-modifying reagent thimerosal
domain and are activated by the direct binding of cyclic ([(O-carboxyphenyl)thio]ethylmercury sodium salt) on
nucleotides (Kaupp et al., 1989). The cyclic nucleotide± wild-type CNG1 channels. Treatment of wild-type CNG1
binding domain of CNG channels shares sequence simi- channels with thimerosal increased the current elicited
larity with other cyclic nucleotide±binding proteins, in- by subsaturating concentrations of cGMP but had little
cluding cGMP- and cAMP-dependent protein kinases effect on the current elicited by saturating concentra-
(PKG and PKA, respectively) and the Escherichia coli tions of cGMP (Figure 1A). This potentiation by thimero-
catabolite gene activator protein (CAP). The crystal sal localized to a single residue, C481 (data not shown),
structures of CAP and PKA have been solved (Weber like the potentiation previously observed by the cyste-
ine-modifying reagents N-ethylmaleimide (NEM) and
methanethiosulfonate ethyltrimethylammonium (MTSET)§ To whom correspondence should be addressed (e-mail: zagotta@
u.washington.edu). (Gordon et al., 1997; Brown et al., 1998).
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Figure 1. Elimination of Effects of Cysteine
Modification
(A) Effects of cysteine-modifying reagents on
wild-type CNG1 channels. The membrane to-
pology illustrating the positions of the seven
endogenous cysteines in CNG1 is shown on
top. Representative current families are shown
from inside-out patches excised from Xeno-
pus oocytes expressing CNG1 channels. Cur-
rents were measured at the indicated cGMP
concentration before and after a 2 min expo-
sure to 250 mM thimerosal in the presence of
2 mM cGMP. Current sweeps were elicited
at the indicated cGMP concentrations by
voltage pulses from 0 mV to potentials be-
tween 280 mV and 180 mV in 20 mV steps.
Leak currents in the absence of cGMP were
subtracted thoughout the paper. The currents
elicited by high concentrations of cGMP ex-
hibit a small sag due to ion accumulation/
depletion, as indicated by the small tail cur-
rents seen when stepping back to 0 mV, the
reversal potential in these symmetrical solu-
tions (Zimmerman et al., 1988). Dose±response
curves for activation by cGMP at 160 mV
before (bow ties) and after (circles) applica-
tion of thimerosal are shown at the bottom.
Dose±response curves and traces are shown
from the same patch. The smooth curves
are fits of the Hill equation, I 5 Imax[cGMP]n/
(K1/2n 1 [cGMP]n), where Imax is the maximum current for each patch at saturating cGMP, K1/2 is the concentration of cGMP producing half-
maximal current, and n is the Hill coefficient. Before thimerosal application: K1/2 5 48.4 mM, Imax 5 4.66 nA, and n 5 2.06. After thimerosal
application: K1/2 5 3.90 mM, Imax 5 4.85 nA, and n 5 1.51.
(B) Effects of cysteine-modifying reagents on the cysteineless channel CNG1c7. The membrane topology of CNG1c7 channels, illustrating
the amino acids replacing the endogenous cysteines, is shown on top. Currents from the cysteineless channel were measured before and
after a 4 min exposure to 500 mM thimerosal in the absence of ligand. The Hill fit shown by the smooth curve has the following parameters:
K1/2 5 7.00 mM, Imax 5 1.49 nA, and n 5 2.10.
Elimination of Endogenous Cysteines (Table 1). The equilibrium constant for the opening allo-
steric transition with cGMP was determined with tetra-To study the effects of the modification of cysteine resi-
dues introduced into the cyclic nucleotide±binding do- caine, as previously described (Fodor et al., 1997). The
concentration of the tetracaine blocking half of the satu-main, we mutated all seven endogenous cysteines of
CNG1 to create a cysteineless channel (CNG1c7) as rating cGMP current (K1/2, tetracaine) was similar for
CNG1c7 and CNG1 channels (Table 1), implying thatfollows: C35A, C169S, C186S, C314S, C481F, C505V,
and C573V. Although thimerosal oxidizes free sulfhydryl these channels have comparable equilibrium constants
for the opening allosteric transition. The similarity ofgroups with high specificity, organomercurials can have
nonspecific effects as well (Brocklehurst, 1979; Chiamvi- CNG1 and CNG1c7 channel function suggests that mu-
tating the endogenous cysteines did not greatly altermonvat et al., 1995). We verified that thimerosal had no
effect on the cysteineless channel by applying 500 mM the structure of the channel.
thimerosal for 4 min to CNG1c7 channels in the absence
of ligand (Figure 1B). Similarly, exposure of CNG1c7 Introduction of Cysteines into the Ligand-Binding
Domain of the Cysteineless Channelchannels to 500 mM thimerosal with ligand or to 10 mM
MTSET either with or without ligand had no effect on We have used the CAP structure to guide our choice
of positions where cysteines were introduced into thethe function of CNG1c7 channels (data not shown).
Hence, all effects of cysteine modification in this study ligand-binding domain of CNG1 channels because many
of the amino acids in the nucleotide-binding pocket ofcan be attributed to the cysteine residues introduced
into the cysteineless construct. CAP are conserved in CNG1 channels (Figure 2A, yel-
low). The cyclic nucleotide±binding domain of CAP con-To verify that mutating the endogenous cysteines did
not dramatically change the structure of the channel, we tains eight b strands, which form a b roll (Figure 2B,
blue), followed by two a helices, designated the B helixcharacterized the gating behavior of CNG1c7 channels.
Mutating the endogenous cysteines decreased the con- (green) and C helix (yellow) (Weber et al., 1987). In the
CAP structure, cAMP (Figure 2B, red) is in the anti con-centration of cGMP that produced half-maximal current
(K1/2, cGMP) (Table 1; Figure 1, bottom). Introduction of figuration.
To study conformational changes occurring in the li-the C481F mutation alone can account for virtually all of
the change in the K1/2 for cGMP (Table 1). The fractional gand-binding domain of the channel during activation,
we introduced individual cysteines in the b roll (C505)activations of saturating cAMP and cIMP compared with
saturating cGMP (Imax,cAMP/Imax,cGMP and Imax,cIMP/Imax,cGMP, re- and in the C helix (G597C) in the cysteineless channel
CNG1c7 (Figure 2A, arrows). Methanethiosulfonate ethyl-spectively) were similar in CNG1 and CNG1c7 channels
Rearrangements in Binding Domain of CNG Channels
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Table 1. Characterization of Functional Properties of Mutant Channels
K1/2 (mM), cGMP Imax,cAMP/Imax,cGMP Imax,cIMP/Imax,cGMP K1/2 (mM), Tetracaine
CNG1 75.1 6 9.1 (n 5 3) 0.02a 0.7a 8.92 6 0.35 (n 5 5)
C481F 10.1 6 0.9 (n 5 13) 0.016 6 0.004 (n 5 5) 0.622 6 0.046 (n 5 2) ND
CNG1c7 8.56 6 0.44 (n 5 15) 0.046 6 0.005 (n 5 12) 0.704 6 0.014 (n 5 17) 10.5 6 2.0 (n 5 4)
C505 10.9 6 0.5 (n 5 20) 0.032 6 0.005 (n 5 15) 0.691 6 0.025 (n 5 20) 10.3 6 1.0 (n 5 5)
G597C 3.69 6 0.23 (n 5 7) 0.100 6 0.008 (n 5 11) 0.700 6 0.052 (n 5 11) 3.69 6 0.61 (n 5 7)
All measurements are mean 6 SEM, recorded at 160 mV. Abbreviation: ND, not determined.
a Data from previous studies (Altenhofen et al., 1991; Goulding et al., 1994; Gordon and Zagotta, 1995; Varnum et al., 1995; Sunderman and
Zagotta, 1999).
ammonium (MTSEA) was previously reported to cause substantially change the K1/2 for cGMP, Imax,cAMP/Imax,cGMP,
Imax,cIMP/Imax,cGMP, or the K1/2 for tetracaine (Table 1). Intro-an irreversible inhibition of the cGMP-activated current
in wild-type CNG1 channels that could be eliminated duction of the G597C mutation into CNG1c7 channels
produced a ,3-fold effect on the K1/2 for cGMP, Imax,cAMP/by mutating C505 (Sun et al., 1996). The positions of
the introduced cysteines are shown in the structural Imax,cGMP, Imax,cIMP/Imax,cGMP, and the K1/2 for tetracaine (Table
1). Since the effects of the C505 and G597C mutationsmodel for the ligand-binding domain of the CNG1 chan-
nel (Figure 2C), generated using the automated compara- are relatively small, we have assumed for the remainder
of this study that the structure of both the C505 channeltive protein±modeling server SWISS-MODEL (Guex and
Peitsch, 1997). and the G597C channel is similar to that of the CNG1c7
channel.Initially, we determined the effects of the C505 and
G597C mutations on the gating of CNG1c7 channels. Next, we examined the effects of the cysteine modifi-
cation of the C505 and G597C channels. Exposure ofIntroduction of C505 into CNG1c7 channels did not
Figure 2. Introduction of Cysteine Residues into the Cyclic Nucleotide±Binding Domain of CNG1c7
(A) Amino acid sequence alignment of the cyclic nucleotide±binding domains of CAP and CNG1. Lines above the sequence indicate secondary
structure motifs present in the crystal structure of CAP; residues in yellow are those that line the ligand-binding pocket of CAP (Weber et al.,
1987). The arrows indicate the positions where cysteine residues were introduced into CNG1c7 channels.
(B) Structure of CAP with bound cAMP (Weber et al., 1987). The b roll is shown in blue, the B helix is shown in green, the C helix is shown
in yellow, and cAMP is shown in red.
(C) Model of the structure of the CNG1 cyclic nucleotide±binding domain using SWISS-MODEL (Guex and Peitsch, 1997), based on the
sequence alignment shown in Figure 2A and the structure of CAP. Positions where cysteines were introduced are shown in magenta.
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Figure 3. Differential Effects of Modification
of C505 and G597C
(A) Representative current families of C505
channels at saturating (8 mM) and subsatur-
ating (8 mM) concentrations of cGMP before
(left) and after (center) a 4 min exposure to
500 mM thimerosal in the absence of ligand
and after an additional 1 min exposure to 10
mM DTT (right).
(B) Representative current families of G597C
channels at saturating (2 mM) and subsatur-
ating (4 mM) concentrations of cGMP before
(left) and after (center) a 30 s exposure to 10
mM MTSET in the absence of ligand and after
an additional 27 min exposure to 10 mM DTT
(right).
C505 channels to thimerosal in the absence of ligand (2) in the presence of saturating cAMP, when most of
the channels are closed and fully liganded (Gordon andcaused a large decrease in the current elicited by sub-
saturating concentrations of cGMP but had no effect Zagotta, 1995; Sunderman and Zagotta, 1999), and (3)
in the presence of saturating cGMP, when most of theon the current elicited by saturating concentrations of
cGMP (Figure 3A, center). The effect of thimerosal was channels are open (Sunderman and Zagotta, 1999) (Fig-
ure 4A). A state-dependent change in the rate of inhibi-completely reversed by exposure to the reducing agent
dithiothreitol (DTT) (Figure 3A, right). Similar exposure tion could be due to either a physical change in the
position of the cysteine residue or a change in the envi-to DTT had no effect on channels that had not been
exposed to thimerosal (data not shown). Thimerosal ronment surrounding the cysteine residue that affects
the reactivity of the thiol group to the reagent. The proto-modification of G597C also inhibited channel activity,
but, in contrast to the effect of thimerosal on C505 chan- cols used to measure time courses of inhibition are dia-
grammed at the top of Figure 4B (see Experimental Pro-nels, the effect of thimerosal on G597C channels re-
versed spontaneously in the absence of DTT (data not cedures). The bottom of Figure 4B shows the time
courses of inhibition of C505 and G597C channels whenshown). Hence, we used MTSET to study modification
of the G597C channels. As opposed to modification of the cysteine-modifying reagent was applied in the ab-
sence of ligand (left), in the presence of saturating cAMPC505 channels, modification of G597C channels with
MTSET in the absence of ligand caused a decrease in (center), or in the presence of saturating cGMP (right).
In each case, the currents elicited by the test solutionthe current elicited by both saturating and subsaturating
concentrations of cGMP (Figure 3B, center). The effect declined with a single exponential rate of decay (smooth
curves). Modification of C505 is much faster in the ab-of MTSET was completely reversed by exposure to DTT
(Figure 3B, right) and did not reverse spontaneously in sence of ligand than in the presence of either saturating
cAMP or cGMP. This state-dependent change in reac-the absence of DTT. These effects of modification of
the ligand-binding domain suggest that modification of tion rate suggests either that the ligand is directly com-
peting for binding with thimerosal at C505 or that theC505 and G597C stabilizes the closed state of the chan-
nel by inhibiting either the initial binding of ligand or the environment surrounding C505 changes as the channel
binds ligand, limiting the accessibility of C505. In con-opening allosteric transition.
To test if the initial binding of ligand or the opening trast, modification of G597C is much faster in the closed
state (both in the absence of ligand and in the presenceallosteric transition alters the accessibility of C505 and
G597C, we determined the rate of inhibition when the of saturating cAMP) than in the open state (in the pres-
ence of saturating cGMP). This suggests that the acces-cysteine-modifying reagent was applied under three ex-
perimental conditions: (1) in the absence of ligand, when sibility of G597C changes during an allosteric conforma-
tional change occurring after the initial binding of ligand.virtually all of the channels are closed and unliganded,
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Figure 4. State Dependence of Modification
of C505 and G597C
(A) Simplified model for channel activation
showing the initial binding of ligand, followed
by an allosteric opening conformational
change. In the absence of ligand, most of
the channels are closed. In the presence of
saturating cAMP, most of the channels are
closed and liganded. In the presence of satu-
rating cGMP, most of the channels are open.
([B], top) Protocol for measuring time courses
of inhibition due to cysteine modification ei-
ther in the absence of ligand (left), in the pres-
ence of saturating cAMP (center), or in the
presence of saturating cGMP (right) (see Ex-
perimental Procedures).
([B], bottom) Time courses of the inhibition
due to cysteine modification of C505 and
G597C channels. Circles show the normal-
ized current at 160 mV in the test solution as
a function of the cumulative time of exposure
to either 500 mM thimerosal or 10 mM MTSET
(applied in the absence of ligand, in the pres-
ence of 16 mM cAMP, or in the presence of
2 mM cGMP). The smooth lines are fit to a
single exponential decay, I/Io 5 If/Io 1 [1 2
(If/Io)]e2kt, where Io is the initial current elicited
by the test solution, If is the final steady-state
current, k is the rate of inhibition, and t is the
cumulative time of cysteine modification. For
each mutant, If/Io was held to the same value
for cysteine modification in each state (0.0438
for C505 channels and 0.0432 for G597C
channels). For C505 modification: in the ab-
sence of ligand, k 5 0.0101 s21; in the pres-
ence of saturating cAMP, k 5 0.0008 s21; in
the presence of saturating cGMP, k 5 0.0009
s21. For G597C modification: in the absence
of ligand, k 5 0.0444 s21; in the presence of
saturating cAMP, k 5 0.0223 s21; and in the
presence of saturating cGMP, k 5 0.0013 s21.
Hence, the differences in the state dependence of modi- The actual state dependence of modification of C505
fication of C505 and G597C suggest that these residues and G597C may be even greater than that measured by
are involved in distinct conformational changes oc- these time courses of inhibition. We often observed a
curring during channel activation. Box plots summariz- small rundown in current while exposing CNG1c7 chan-
ing the rates of inhibition for multiple patches are shown nels to cysteine-modifying reagents over the course
in Figure 5. of the experiment. This small rundown, similar to the
amount of inhibition seen with C505 channels modified
in the presence of ligand and with G597C channels mod-
ified in the presence of cGMP, showed little or no revers-
ibility with DTT and is most likely due to a slow loss in
channel function that is independent of cysteine modi-
fication. Additionally, tetracaine experiments suggest
that the allosteric transition with cGMP is less favorable
for G597C channels than for CNG1c7 channels and that
G597C channels are closed z10% of the time at sat-
urating concentrations of cGMP. Potentiation by Ni21
was also used as a tool to estimate the equilibrium
constant for the allosteric transition, as previously de-
scribed (Gordon and Zagotta, 1995; Sunderman and Za-
Figure 5. Summary of State-Dependent Modification of C505 and gotta, 1999), and results also supported the conclusions
G597C of the tetracaine experiments (data not shown). This
Box plots summarizing the rate of inhibition due to cysteine modifi- implies that some of the observed inhibition in G597C
cation of C505 (left) and G597C (right) applied either in the absence channels modified in the presence of saturating cGMP
of ligand or in the presence of saturating cAMP or cGMP. The
is due to modification of closed channels and that thehorizontal line within each box indicates the median of the data;
true rate of inhibition of open G597C channels is evenboxes show the twenty-fifth and seventy-fifth percentiles of the
data; whiskers show the fifth and ninety-fifth percentiles of the data. slower than that measured in saturating cGMP.
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Figure 6. Effects of Modification of C505 and
G597C on the Dose±Response Relations
(A) Dose±response curves for activation by
cGMP of C505 channels. Squares represent
currents measured before modification (n 5
6), triangles represent currents measured fol-
lowing a 4 min exposure to 500 mM thimerosal
in the absence of ligand (n 5 3), and dia-
monds represent currents measured follow-
ing an 8 min exposure to thimerosal (n 5 3).
Data were normalized to compare multiple
patches by dividing the current measured at
each concentration by the maximal current
elicited by cGMP in unmodified channels.
Currents were measured at 160 mV. The
smooth curves are fits of the model described in Figure 7A, with K 5 25,000 M21, L 5 20, x 5 45, and t 5 200 s.
(B) Dose±response curves for activation by cGMP of G597C channels. Currents were measured at 160 mV following 0, 20, 29, and 39 s
effective exposures to 10 mM MTSET in the absence of ligand (squares, triangles, diamonds, and bow ties, respectively). Effective exposure
times accounted for the rate of decay of MTSET (see Experimental Procedures). Data were normalized by dividing the current measured at
each concentration by the maximal current elicited by cGMP in unmodified channels. The smooth curves are fits of the model described in
Figure 7B, with K 5 100,000 M21, L 5 11.2, y 5 50, t 5 30 s, and tM 5 2,100 s.
To more rigorously test the idea that the regions in- exposure to the cysteine-modifying reagent (see Experi-
mental Procedures).cluding C505 and G597C might be involved in separate
conformational changes in the ligand-binding domain, The effects of the modification of C505 can be de-
scribed by a model in which cysteine modification af-we examined the effects of applying cysteine-modifying
reagents for various amounts of time on the cGMP dose± fects only the equilibrium constant for the initial binding
of ligand to a single subunit (K) (Figure 7A). Modificationresponse curves. Modification of C505 in the absence
of ligand shifted the dose±response curve to the right, decreases K for a given subunit by a factor of x. When
the channels are unliganded, C505 is in a conformationincreasing the cGMP apparent affinity but having little
or no effect on the current elicited by saturating cGMP that is accessible to the cysteine-modifying reagent.
After each subunit binds ligand, C505 is no longer acces-concentrations (Figure 6A). Modification was not com-
plete, as evidenced by the fact that longer exposures to sible to the cysteine-modifying reagent. The smooth
curves in the dose±response relations in Figure 6A arethimerosal had a larger effect. Additionally, modification
changed the shape of the cGMP dose±response curve, fits of the model shown in Figure 7A (see Experimental
Procedures). The heterogeneity in the number of sub-making the curve shallower at higher cyclic nucleotide
concentrations. The effect of the cysteine modification units modified can explain the change in the shape of
the cGMP dose±response curves. To fit the initial dose±of G597C on the cGMP dose±response curve is distinct
from that of C505, as shown for a representative patch response curves from unmodified channels to the ob-
served Hill coefficient of 2, we used a model with twoin Figure 6B. Dose±response curves of G597C channels
were measured following various effective exposure subunits, although the channels form as tetramers. We
expect qualitatively similar results in a more complextimes to MTSET in the absence of ligand. In contrast
to C505, modification of G597C greatly decreased the model that considers the cysteine modification of all
four subunits. The ability of the cGMP dose±responsecurrent elicited by saturating cGMP concentrations but
only slightly increased the apparent affinity for cGMP. curves of C505 channels to be fit by a model in which
cysteine modification affects only initial ligand binding,Again, modification was not complete, as evidenced by
the larger effects of longer exposures to MTSET. combined with the state-dependent accessibility of this
residue, suggests that this region of the channel (the b
roll) is involved in the initial binding of ligand.Discussion
The effects of the modification of G597C can be de-
scribed by a model in which cysteine modification af-The different effects of the cysteine modification of C505
and G597C can be explained by distinct mechanisms fects only the opening allosteric conformation change
occurring after the ligand has initially bound (Figure 7B).of inhibition. Models that show the effect of cysteine-
modifying reagents on initial ligand binding and the Modification decreases the equilibrium constant for the
allosteric transition (L) for each subunit by a factor ofopening allosteric conformational change are shown in
Figure 7. Two subunits are shown, each containing a y. In this case, the channel is accessible to cysteine-
modifying reagent when the channels are closed (eithercyclic nucleotide±binding domain. The independent ini-
tial binding of two cyclic nucleotides (shown by trian- with ligand bound or not bound) but not when the chan-
nels are open. The smooth curves in the dose±responsegles) is followed by a concerted allosteric conforma-
tional change that opens the pore. Cysteine-modifying curves in Figure 6B are fits of the model shown in Figure
7B. The large change in maximal cGMP current, withreagent binds independently to multiple subunits (shown
by closed circles). The proportion of channels with a little change in the apparent affinity for cGMP, can be
explained if the binding of MTSET to a single subunitgiven number of modified sites was calculated assuming
a binomial distribution where p, the probability of modifi- causes a large decrease in the equilibrium constant for
the opening allosteric transition, and modification of acation of a given subunit, is a function of the time of
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Figure 7. Models Describing Inhibition of C505 and G597C Channels by Cysteine-Modifying Reagents
(A) The effect of thimerosal on C505 channels can be explained by a model in which thimerosal affects only the initial binding of ligand (K),
binding to C505 primarily when the channel is closed and unliganded. Two subunits are shown, each containing a cyclic nucleotide±binding
domain. The triangles represent cyclic nucleotide, and the circles represent cysteine-modifying reagent. The proportion of channels with a
given number of modified sites was calculated assuming a binomial distribution, with p, the probability of modification of a single subunit, a
function of the time of exposure to cysteine-modifying reagent.
(B) The effect of MTSET on G597C channels can be explained by a model in which MTSET affects only an opening allosteric conformational
change (L), binding to G597C primarily when the channel is closed.
second subunit eliminates almost all channel function. Imax,cAMP/Imax,cGMP at 160 mV from 0.032 6 0.005 (n 5 15)
to 0.014 6 0.002 (n 5 3) and Imax,cIMP/Imax,cGMP at 160 mVAlthough this model only considers the binding of cyste-
ine-modifying reagent to two subunits, we observed from 0.691 6 0.025 (n 5 20) to 0.311 6 0.011 (n 5 3).
Since even a 2-fold effect of modification on the alloste-very little difference when we fit the data in Figure 6B
to a more complex model that considers the cysteine ric transition would have been apparent with saturating
cGMP, this effect of modification of C505 is cyclic nucle-modification of all four subunits (data not shown). The
only significant difference between the fits with two and otide specific and must arise from differences in the way
the cyclic nucleotides interact with the binding domainfour subunits was in t, a measure of the rate of chemical
modification of a single subunit. t was twice as large during the allosteric transition. Although we cannot rule
out the possibility that thimerosal modification of C505(60 s versus 30 s) using the tetrameric model, since
twice as many sites were available for chemical modifi- has a small effect on the opening allosteric equilibrium
for cGMP, much of the effect of C505 modification cancation. The ability of a model in which cysteine modifica-
tion affects only an opening allosteric transition to fit be explained by a model affecting only initial ligand
binding.the cGMP dose±response curves of G597C channels,
combined with the state-dependent accessibility of this The results of this study, combined with the known
structure of CAP, support a molecular mechanism inresidue, suggests that this region of the channel (the C
helix) is involved in an opening allosteric conformational which ligand initially binds to the closed channel pri-
marily through interactions between the b roll structurechange following the initial binding of ligand.
Modification of G597C with 10 mM MTSET for 30 s and the ribose and phosphate of the cyclic nucleotide,
and the opening allosteric conformational change in-caused a large decrease in the current elicited by satu-
rating concentrations (16 mM) of cAMP and cIMP, de- volves the movement of the b roll relative to the C helix
(Figure 8). This mechanism was previously proposedcreasing Imax,cAMP/Imax,cGMP at 160 mV from 0.100 6 0.008
(mean 6 SEM, n 5 11) to 0.01300 6 0.00002 (n 5 2) and based on the observations that substitution of D604 in
the C helix dramatically alters the opening allostericImax,cIMP/Imax,cGMP at 160 mV from 0.700 6 0.052 (n 5 11)
to 0.135 6 0.014 (n 5 2). A model in which cysteine transition, whereas substitution of T560 and R559 in the
b roll affects initial binding (Varnum et al., 1995; Tibbsmodification affects the opening allosteric transition ac-
curately predicts this decrease in current elicited by et al., 1998). This study uses a more direct approach to
study molecular rearrangements occurring in the ligand-saturating concentrations of ligand. In contrast, a model
in which modification affects only the initial binding of binding domain. Modification of C505 in the b roll is
prevented by the binding of either cAMP or cGMP, whichligand does not predict a decrease in the current elicited
by saturating concentrations of ligand. Thimerosal mod- have identical ribose and phosphate rings. Hence, modi-
fication of the b roll interferes with the initial binding ofification of C505 did not change the current elicited by
saturating concentrations of cGMP. However, modifica- ligand. In contrast, modification of G597C in the C helix
does not interfere with initial ligand binding but inhibitstion of C505 with 500 mM thimerosal for 4 min decreased
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Figure 8. Molecular Mechanism for Confor-
mational Changes Occurring in the Ligand-
Binding Domain
Model of the cyclic nucleotide±binding site
of the CNG channel is based on the structure
of CAP. The ligand initially binds to the closed
channel primarily through interactions be-
tween the b roll structure and the ribose and
phosphate of the cyclic nucleotide. The open-
ing allosteric conformational change involves
the movement of the b roll relative to the C
helix.
and NiCl2 were purchased from Sigma (St. Louis, MO), and MTSETthe opening allosteric transition by preventing move-
was purchased from Toronto Research Chemicals (North York, ON,ment of the b roll relative to the C helix. Finally, these
Canada).studies suggest that cysteine modification can be a use-
ful tool in probing the conformational changes occurring Time Course Protocol
in the cyclic nucleotide±binding domain in order to bet- Time courses of inhibition due to cysteine modification in the various
ter understand the molecular mechanisms involved in states shown in Figure 4 were measured by exposing the patch for
discrete amounts of time (3±30 s) to the following series of solutions:channel activation.
(1) test solution (8 mM cGMP for C505 channels and 250 mM cGMP
for G597C channels), (2) wash solution (containing no ligand, 16 mM
cAMP, or 2 mM cGMP), (3) cysteine-modifying reagent in wash
Experimental Procedures
solution, and (4) wash solution (repeated). This series was repeated
either until the current elicited by the test solution reached a steady-
Molecular Biology
state level or for as long as possible. For modification in the presence
The cDNA for CNG1 was cloned as previously described (Gordon
of saturating cAMP or cGMP, a control solution was interspersed
and Zagotta, 1995). The amino acid sequence was identical to the
between the test solution and the wash solution to measure leak
published sequence (Kaupp et al., 1989), except for a K2E mutation
current in the absence of ligand. In each solution, the voltage was
and the addition of an eight amino acid Flag epitope tag
stepped two to ten times from a holding potential of 0 mV to 260
(DYKDDDDK) that replaces the last five amino acids (DSTQD) on
mV for 100 ms and then to 160 mV for 100 ms before it was returned
the C terminus. These changes did not alter any of the measured
to 0 mV.
properties of CNG1 (data not shown). This cDNA was subcloned
into a high-expression vector, kindly provided by E. R. Liman, that
Analysiscontains the untranslated sequences of the Xenopus b-globin gene
Figure 7A illustrates a model in which cysteine modification affects(Liman et al., 1992). Mutant cDNAs were constructed by a PCR-
the equilibrium constant for the initial binding of ligand (K). Thebased method, as previously described (Gordon and Zagotta, 1995)
probability of the channel being in a conducting state, Po, was calcu-and were verified by sequence analysis. cRNA was transcribed in
lated according to the following equation:vitro with the mMessage mMachine kit (Ambion, Austin, TX).
Po 5 (1 2 p)2 5 K2[cG]2L1 1 2K[cG] 1 K2[cG]2 1 K2[cG]2L6
Electrophysiology
Xenopus oocytes were prepared and injected with cRNA as pre-
12p(1 2 p)5 (K2/x)[cG]2L1 1 2K[cG] 1 (K/x)[cG] 1 (K2/x)[cG]2 1 (K2/x)[cG]2L6viously described (Zagotta et al., 1989). After 2±10 days of incubation
at 168C, channel function was assayed by patch-clamp recording
in the inside-out configuration (Hamill et al., 1981). Data were ac- 1p25 (K/x)2[cG]2L1 1 2(K/x)[cG] 1 (K/x)2 [cG]2 1 (K/x)2[cG]2L6quired and analyzed with Pulse software (Instrutech, Elmont, NY).
Currents were filtered at 2 kHz and sampled at 10 kHz. Recordings
where p is the probability that cysteine-modifying reagent has modi-
were measured at room temperature (z208C) using 0.3±1.5 MV bo- fied a single subunit, K is the equilibrium constant for the initial
rosilicate pipettes. Upon excision, currents often tended to ªrun upº binding of cGMP to a single subunit, L is the equilibrium constant
slowly (Molokanova et al., 1997). We waited z5±10 min for each of the allosteric transition from the fully liganded closed state to the
patch to reach an equilibrium level to begin experiments. Control open state, [cG] is the concentration of cGMP, and x is the fold
currents in the absence of cyclic nucleotide were subtracted. effect of cysteine modification on the cGMP association constant
Intracellular and extracellular solutions contained 130 mM NaCl, for each subunit. L was determined by comparing the K1/2 for tetra-
200 mM EDTA, and 3 mM HEPES (pH 7.2). Intracellular solutions caine and the potentiation by Ni21 to the corresponding properties
containing cyclic nucleotides, cysteine-modifying reagents, or tetra- of wild-type channels, as previously described (Gordon and Zagotta,
caine were changed with an RSC-100 rapid solution changer (Molec- 1995; Fodor et al., 1997; Sunderman and Zagotta, 1999). K was
ular Kinetics, Pullman, WA). A 100 mM stock solution of thimerosal determined from the cGMP dose±response curve before modifica-
in water was made fresh each day and diluted to a final concentration tion. This model assumes a binomial distribution of cysteine modifi-
of 250±500 mM in NaCl/EDTA/HEPES solution with either 2 mM cation to two subunits. We calculated p, assuming independent
cGMP, 16 mM cAMP, or no cyclic nucleotide as indicated. A 50 mM binding of cysteine-modifying reagent to each subunit, according
stock solution of MTSET in water was stored on ice for ,2 hr and to the following equation:
diluted to a final concentration of 10 mM in NaCl/EDTA/HEPES solu-
p 5 1 2 e2
t
ttion with either 2 mM cGMP, 16 mM cAMP, or no cyclic nucleotide
immediately before the first application in each experiment. DTT
was made as a 100 mM stock in NaCl/EDTA/HEPES solution and where t is the exposure time to cysteine-modifying reagent, and t
diluted to 10 mM in NaCl/EDTA/HEPES solution within 2 days of is the time constant for the chemical modification of a single subunit.
use. For Ni21 potentiation experiments, 500 mM niflumic acid was Figure 7B illustrates a model in which cysteine modification af-
added to the extracellular solution, and EDTA in the intracellular fects an opening allosteric transition occurring after the ligand has
solution was replaced by 1 mM NiCl2. Tetracaine and NiCl2 solutions fully bound. The probability of the channel being in a conducting
state in this case is described by the following equation:were used within 1 week. Cyclic nucleotides, thimerosal, tetracaine,
Rearrangements in Binding Domain of CNG Channels
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tetracaine block of cyclic nucleotide±gated channels. J. Gen. Phys-
Po 5 (1 2 p)2 5 K2[cG]2L1 1 2K[cG] 1 K2[cG]2 1 K2[cG]2L6 iol. 109, 3±14.
Gordon, S.E., and Zagotta, W.N. (1995). A histidine residue associ-
ated with the gate of the cyclic nucleotide±activated channels in12p(1 2 p)5 K2[cG]2(L/y)1 1 2K[cG] 1 K2[cG]2 1 K2[cG]2 (L/y)6 rod photoreceptors. Neuron 14, 177±183.
Gordon, S.E., Varnum, M.D., and Zagotta, W.N. (1997). Direct inter-
1p25 K2[cG]2(L/y2)1 1 2K[cG] 1 K2[cG]2 1 K2[cG]2(L/y2)6 action between amino- and carboxyl-terminal domains of cyclic
nucleotide±gated channels. Neuron 19, 431±441.
where p, L, K, and [cG] are as defined above, and y is the fold effect Goulding, E.H., Tibbs, G.R., and Siegelbaum, S.A. (1994). Molecular
of each cysteine modification on the equilibrium constant for the mechanism of cyclic-nucleotide-gated channel activation. Nature
allosteric transition. We determined L, K, and p as described above. 372, 369±374.
The smooth curves shown on the top of Figure 6 plot Po,Po,max as a Guex, N., and Peitsch, M.C. (1997). SWISS-MODEL and the Swiss-
function of [cGMP], where PdbViewer: an environment for comparative protein modeling. Elec-
trophoresis 18, 2714±2723.
Po,max 5
L
L 1 1 Hamill, O.P., Marty, A., Neher, E., Sakmann, B., and Sigworth, F.J.
(1981). Improved patch-clamp techniques for high-resolution cur-
rent recording from cells and cell-free membrane patches. PfluÈ gersTo correct for the decay of MTSET during the long experiment
Arch. 391, 85±100.shown in Figure 6B, we assumed a single exponential rate of decay
for MTSET. This correction was done according to the following Henn, D.K., Baumann, A., and Kaupp, U.B. (1995). Probing the trans-
equation: membrane topology of cyclic nucleotide±gated ion channels with a
gene fusion approach. Proc. Natl. Acad. Sci. USA 92, 7425±7429.
te 5 tMhe2(tM/tM)2e2[(tM 1 ta)/tM]j
Jan, L.Y., and Jan, Y.N. (1990). A superfamily of ion channels. Nature
345, 672.where te is the effective time of exposure, tM is the time constant
Karpen, J.W., Zimmerman, A.L., Stryer, L., and Baylor, D.A. (1988).of the decay of MTSET (found to be 35 min), tM is the age of the
Gating kinetics of the cyclic-GMP-activated channel of retinal rods:MTSET solution in NaCl/EDTA/HEPES, and ta is the actual time that
flash photolysis and voltage-jump studies. Proc. Natl. Acad. Sci.the patch was exposed to MTSET.
USA 85, 1287±1291.
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